NewAmsterdam Pharma Company NV Ordinary Shares
Price & Volume
Stats
See more52W Range | $17.63-$42.20 |
Market Cap | $3.5B |
Shares Short | 8M |
Financials
See moreRevenue (12 Mos) | $22.5M |
Revenue Growth (YoY) | 2.1% |
Gross Profit (12 Mos) | $22.5M |
Diluted EPS | -$1.78 |
News
See moreYahoo Finance • 12 days ago
Billionaire Stanley Druckenmiller Likes This Small-Cap Pharma Stock in 2026
Yahoo Finance • 20 days ago
Why This Fund Made a $66 Million Bet on Damora Therapeutics Amid a 700% Surge
Yahoo Finance • 21 days ago
Dyne Stock Is Up 56%. Here's What a $14 Million Stake Reduction Could Mean
Yahoo Finance • 2 months ago
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
About
CEO | Dr. Michael Harvey Davidson FACC, Facp., M.D. |
Address | Gooimeer 2-35, Naarden, Netherlands, 1411 DC |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 100 |